Defined Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $403K | Sell |
905
-17
| -2% | -$7.57K | 0.25% | 85 |
|
|
2025
Q1 | $447K | Buy |
922
+7
| +0.8% | +$3.39K | 0.3% | 79 |
|
|
2024
Q4 | $368K | Buy |
915
+3
| +0.3% | +$1.21K | 0.24% | 87 |
|
|
2024
Q3 | $424K | Buy |
912
+14
| +2% | +$6.51K | 0.28% | 79 |
|
|
2024
Q2 | $421K | Buy |
898
+12
| +1% | +$5.63K | 0.29% | 76 |
|
|
2024
Q1 | $370K | Hold |
886
| – | – | 0.27% | 85 |
|
|
2023
Q4 | $361K | Sell |
886
-2
| -0.2% | -$814 | 0.28% | 84 |
|
|
2023
Q3 | $309K | Buy |
888
+7
| +0.8% | +$2.43K | 0.26% | 86 |
|
|
2023
Q2 | $310K | Buy |
881
+1
| +0.1% | +$352 | 0.26% | 83 |
|
|
2023
Q1 | $277K | Hold |
880
| – | – | 0.26% | 87 |
|
|
2022
Q4 | $254K | Hold |
880
| – | – | 0.24% | 93 |
|
|
2022
Q3 | $255K | Hold |
880
| – | – | 0.28% | 77 |
|
|
2022
Q2 | $248K | Sell |
880
-13
| -1% | -$3.66K | 0.25% | 83 |
|
|
2022
Q1 | $233K | Buy |
+893
| New | +$233K | 0.2% | 91 |
|
|
2021
Q1 | – | Sell |
-880
| Closed | -$208K | – | 200 |
|
|
2020
Q4 | $208K | Buy |
+880
| New | +$208K | 0.21% | 85 |
|